Trial Profile
Clinical Trials Insight: 700051847
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 23 Dec 2009
Price :
$35
*
At a glance
- Drugs Golvatinib (Primary) ; Antineoplastics
- Indications Liver cancer
- Focus Therapeutic Use
- 23 Dec 2009 New trial record.